Şunu aradınız:: season (Danca - İtalyanca)

guidelines final eu recommendations for the influenza vaccine composition for the season 2000/ 2001
influenza vaccine composition for the season 2000/ 2001 report of the emea expert workshop on

committee for proprietary medicinal products (cpmp), final eu recommendations for the influenza vaccine composition for the season 2002/ 2003
committee for proprietary medicinal products (cpmp), final eu recommendations for the influenza vaccine composition for the season 2002/ 2003

da effekten af palivizumab, når den gives til patienter for anden gang i løbet af en rsv season, ikke er blevet formelt undersøgt i et studie gennemført med dette formål, er relevansen af disse data fra et effektsynspunkt ikke kendte.
comunque siccome l’ efficacia del palivizumab quando somministrato a pazienti come secondo ciclo di trattamento durante l’ insorgenza della stagione vrs non è stata formalmente investigata in uno studio condotto con questo obiettivo, è sconosciuta la rilevanza di questi dati in termini di efficacia.

titel på dokumentet revision of note for guidance on minimising the risks of tse transmission via medicinal products cpmp recommendations on vcjd and plasma derived medicinal products – cpmp recommendations on transmissible agents and urinary derived medicinal products note for guidance on the use of bovine serum used in the manufacture of human biological medicinal products note for guidance on the production and quality control of animal immunoglobins and immunosera for human use cell culture inactivated influenza vaccines – annex to note for guidance on harmonisation of requirements for influenza vaccines eu recommendations for the influenza vaccine composition for the season 2002/ 2003 plasma master file:
titolo del documento revision of note for guidance on minimising the risks of tse transmission via medicinal products cpmp recommendations on vcjd and plasma derived medicinal products – cpmp recommendations on transmissible agents and urinary derived medicinal products note for guidance on the use of bovine serum used in the manufacture of human biological medicinal products note for guidance on the production and quality control of animal immunoglobins and immunosera for human use cell culture inactivated influenza vaccines – annex to note for guidance on harmonisation of requirements for influenza vaccines eu recommendations for the influenza vaccine composition for the season 2002/ 2003 plasma master file: